Prophylaxis of infective endocarditis: a reevaluation.

Area of Science:

• Cardiology
• Infectious Diseases
• Pharmacology

Background:

• Established practice involves administering antimicrobial prophylaxis to prevent infective endocarditis (IE) in patients with cardiovascular disease undergoing procedures associated with bacteremia.
• Current prophylaxis regimens are based on expert recommendations, with limited direct evidence of efficacy in humans, though few IE cases have been reported in treated at-risk individuals.

Purpose of the Study:

• To evaluate the efficacy of current antimicrobial prophylaxis regimens for preventing IE in at-risk patients.
• To address theoretical questions regarding current IE prophylaxis recommendations raised by experimental studies in rabbits.
• To propose a framework for modifying and testing IE prophylaxis regimens based on documented clinical data.

Main Methods:

• Review of existing clinical practice and reported IE cases in patients receiving American Heart Association-recommended prophylaxis.
• Analysis of experimental IE prevention studies in rabbits.
• Proposal for prospective studies to document IE occurrence in patients on established antibiotic regimens.

Main Results:

• Very few IE cases have been reported in at-risk patients adhering to recommended prophylaxis.
• Experimental rabbit studies suggest potential limitations of current human prophylaxis regimens, prompting calls for revision.
• Direct translation of rabbit study findings to human recommendations is questioned.

Conclusions:

• Further studies are needed to document IE occurrence in patients receiving established antibiotic prophylaxis regimens.
• Data from such studies can inform modifications to current IE prophylaxis, potentially simplifying treatment (e.g., oral vs. parenteral, single vs. multiple doses).
• Investigating IE failures can provide rationale for refining prophylaxis strategies.